Arad U - Search Results

1

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.

Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T, Fuller A, Rosenthal A, Becce F, Bardin T, Ea HK, Filippou G, FitzGerald J, Iagnocco A, Lioté F, McCarthy GM, Ramonda R, Richette P, Sivera F, Andres M, Cipolletta E, Doherty M, Pascual E, Perez-Ruiz F, So A, Jansen TL, Kohler MJ, Stamp LK, Yinh J, Adinolfi A, Arad U, Aung T, Benillouche E, Bortoluzzi A, Dau J, Maningding E, Fang MA, Figus FA, Filippucci E, Haslett J, Janssen M, Kaldas M, Kimoto M, Leamy K, Navarro GM, Sarzi-Puttini P, Scirè C, Silvagni E, Sirotti S, Stack JR, Truong L, Xie C, Yokose C, Hendry AM, Terkeltaub R, Taylor WJ, Choi HK. Abhishek A, et al. Among authors: arad u. Arthritis Rheumatol. 2023 Oct;75(10):1703-1713. doi: 10.1002/art.42619. Epub 2023 Jul 26. Arthritis Rheumatol. 2023. PMID: 37494275 Free PMC article.

2

Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.

Nassir M, Arad U, Lee SY, Journo S, Mirza S, Renn C, Zimmermann H, Pelletier J, Sévigny J, Müller CE, Fischer B. Nassir M, et al. Among authors: arad u. Purinergic Signal. 2019 Jun;15(2):247-263. doi: 10.1007/s11302-019-09649-2. Epub 2019 Apr 25. Purinergic Signal. 2019. PMID: 31025169 Free PMC article.

3

Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo.

Wong E, Cohen T, Romi E, Levin M, Peleg Y, Arad U, Yaron A, Milla ME, Sagi I. Wong E, et al. Among authors: arad u. Sci Rep. 2016 Dec 16;6:35598. doi: 10.1038/srep35598. Sci Rep. 2016. PMID: 27982031 Free PMC article.

4

Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage.

Chorin E, Hochstadt A, Arad U, Ghantous E, Gertel S, Levartovsky D, Litinsky I, Elaluof O, Polachek A, Kaufman I, Aloush V, Borok S, Wigler I, Wollman J, Caspi D, Laufer-Perl M, Letourneau-Shesaf S, Berliner S, Elkayam O, Topilsky Y, Paran D. Chorin E, et al. Among authors: arad u. Lupus. 2020 Oct;29(11):1430-1437. doi: 10.1177/0961203320947805. Epub 2020 Aug 9. Lupus. 2020. PMID: 32772796

5

Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatment.

Paran D, Smith Y, Pundak S, Arad U, Levartovsky D, Kaufman I, Wollman J, Furer V, Broyde A, Elalouf O, Caspi D, Pel S, Elkayam O. Paran D, et al. Among authors: arad u. Curr Med Res Opin. 2018 Oct;34(10):1777-1783. doi: 10.1080/03007995.2018.1443581. Epub 2018 Mar 23. Curr Med Res Opin. 2018. PMID: 29569514

6

Diffuse scalp alopecia in a middle-aged patient.

Samuelov L, Arad U, Gat A, Pavlovsky M, Sprecher E, Matz H. Samuelov L, et al. Among authors: arad u. Clin Exp Dermatol. 2013 Dec;38(8):936-9. doi: 10.1111/ced.12091. Epub 2013 Jun 10. Clin Exp Dermatol. 2013. PMID: 23745963 No abstract available.

7

Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab.

Furer V, Zisman D, Kaufman I, Arad U, Berman M, Sarbagil-Maman H, Elias M, Hadad A, Paran D, Drori Y, Friedman N, Mandelboim M, Elkayam O. Furer V, et al. Among authors: arad u. Vaccine. 2020 Jan 22;38(4):847-851. doi: 10.1016/j.vaccine.2019.10.081. Epub 2019 Nov 22. Vaccine. 2020. PMID: 31767465

8

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.

Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O. Arad U, et al. Vaccine. 2011 Feb 11;29(8):1643-8. doi: 10.1016/j.vaccine.2010.12.072. Epub 2011 Jan 4. Vaccine. 2011. PMID: 21211590

9

QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study.

Shovman O, Anouk M, Vinnitsky N, Arad U, Paran D, Litinsky I, Caspi D, Elkayam O. Shovman O, et al. Among authors: arad u. Int J Tuberc Lung Dis. 2009 Nov;13(11):1427-32. Int J Tuberc Lung Dis. 2009. PMID: 19861018

10

A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants.

Arad U, Ben-Nun-Shaul O, El-Latif MA, Nissim O, Oppenheim A. Arad U, et al. Virology. 2002 Dec 20;304(2):155-9. doi: 10.1006/viro.2002.1791. Virology. 2002. PMID: 12504557 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page